What happens when a drug doesn’t work as expected, particularly when the consequences are a matter of life and death? And how should we think about responsibility when individual biology influences how someone responds to medication?
In this episode of the Smooth Brain Society, host Sahir Hussain is joined by geneticist Dr Qurratulain ‘Annie’ Hasan (Kamineni Hospitals, India) and Dr Pantea Javedan (Stanford University, USA), whose work focuses on human rights and trauma mental health. Together, they explore the intersection of pharmacogenetics, precision medicine, ethics and the legal system, drawing on the cases of Christa Pike and Elijah McClain in the United States.
The conversation examines how genetic and biological differences can influence drug responses, and what this means for medical decision-making, police encounters and capital punishment. We also discuss racial bias, trauma, consent and the wider question of institutional accountability.
Ultimately, if we can better understand how individuals respond to medication, what responsibilities do healthcare professionals and institutions have to account for those differences?
Chapters:
00:00 Why drug response matters in life-and-death decisions
02:15 Christa Pike and the genetics of drug metabolism
09:11 Elijah McClain, ketamine, and emergency response
12:28 Genetic variation, race, and standard dosing
23:42 Assisted dying, consent, and coercion
33:32 Training, institutional protocols, and racial bias
45:33 Where pharmacogenomic testing is entering routine care
51:09 How clinical trials and drug labels could account for genetics
55:15 Safeguards, patient advocacy, and legal responsibility